Skip to main content

Table 8 (abstract P375). Univariate analysis of clinicopathologic prognostic factors for survival in 186 patients

From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Variable

 

n

m DFS

p-value

m OS

p-value

Sex

Male

127

53.0

0.335

54

0.225

Female

59

57.0

 

63.0

 

Age

<65

128

55.0

0.196

56.0

0.259

≥65

58

43.0

 

54.0

 

Histological guide

G1-G2

78

55.0

0.375

57.0

0.452

G3-G4

108

53.0

 

55.0

 

Stage

I

18

72.0

0.024

72.0

0.040

II

43

55.0

 

64.0

 

III

125

34.0

 

54.0

 

Tumor location

EGJ

70

43.0

0.123

54.0

0.136

Gastric

116

56.0

 

57.0

 

CD8+ T-cells

IHC=0

22

22.0

0.003

36.0

0.001

IHC=1

66

53.0

 

55.0

 

IHC=2

77

54.0

 

56.0

 

IHC=3

21

60.0

 

65.0

 

PD-P1 status

TC=0 and IC=0

74

53.0

0.333

55.0

0.276

TC=1 or IC=1

45

47.0

 

55.0

 

TC=2 or IC=2

44

54.0

 

56.0

 

TC=3 or IC=3

23

56.0

 

57.0

 
Back to article page